The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

George D. Demetri, Margaret von Mehren, Charles D. Blanke et al. · New England Journal of Medicine · 2002 · 4.4K citations · Full text

Medicine, Oncology, Pharmacology +14

Two Hundred Gastrointestinal Stromal Tumors

Ronald P. DeMatteo, Jonathan J. Lewis, Denis H. Y. Leung et al. · Annals of Surgery · 2000 · 2.5K citations · Full text

Medicine, Oncology, Surgery +15

Hepatobiliary Cancers

Al B. Benson, Thomas A. Abrams, Edgar Ben‐Josef et al. · Journal of the National Comprehensive Cancer Network · 2009 · 2.3K citations · Full text

Medicine, Oncology, Pathology +14

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

Ronald P. DeMatteo, Karla V. Ballman, Cristina R. Antonescu et al. · The Lancet · 2009 · 1.4K citations · Full text

Medicine, Oncology, Surgery +11

Gastrointestinal Stromal Tumors of the Stomach

Markku Miettinen, Leslie H. Sobin, Jerzy Lasota · The American Journal of Surgical Pathology · 2004 · 1.2K citations

Medicine, Oncology, Pathology +17